| Accession |
PRJCA011466 |
| Title |
A study to evaluate the safety and efficacy of brivaracetam in subjects with partial seizures with or without secondary generalization |
| Relevance |
Medical |
| Data types |
Clinical Data
|
| Organisms |
Homo sapiens
|
| Description |
This is an open-label multicenter, follow-up study to evaluate the long-term safety and efficacy of brivaracetam (BRV) used as adjunctive treatment in subjects equal or greater than 16 years with partial seizures with or without secondary generalization. The primary objective is to evaluate the longterm safety and tolerability of BRV in focal epilepsy subjects with partial seizures. The secondary objective is to evaluate the maintenance of efficacy of BRV over time. |
| Sample scope |
General laboratory test data |
| Release date |
2022-08-26 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| UCB Biopharma SPRL
|
|
N/A
|
|
|
|
| Submitter |
Xintong
Wu (36853839@qq.com)
|
| Organization |
West China Hospital of Sichuan University |
| Submission date |
2022-08-26 |
